Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supervised vs Unsupervised Primaquine for Malaria in Ethiopia
NCT02793388Phase 4Withdrawn
- Sponsor
- Menzies School of Health Research
- Start
- Sep 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of primaquine in malaria and Plasmodium falciparum malaria (2 arms), sponsored by Menzies School of Health Research. Primary endpoint: The incidence risk of symptomatic P. vivax malaria over 4 months in patients enrolled with P. vivax or P. falciparum malaria. Planned start Sep 2016; status: withdrawn.
02
Drugs
primaquine
03
Conditions
malariaPlasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02793388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793388.